Skip to main content
Subscribe
Log In
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
Basket
Search
More
Search for this keyword
Advanced search
Latest content
Current issue
Archive
Authors
About
Podcasts
Search for this keyword
Advanced search
Close
More
Main menu
Latest content
Current issue
Archive
Authors
About
Podcasts
Subscribe
Log in
More
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
BMJ Journals
You are here
Home
Archive
Volume 81, Issue 10
Guselkumab for treating immune checkpoint inhibitor-induced psoriatic arthritis
Email alerts
Article metrics
Article menu
Article
Text
Article
info
Citation
Tools
Share
Rapid Responses
Article
metrics
Alerts
PDF
Letter
Guselkumab for treating immune checkpoint inhibitor-induced psoriatic arthritis
Online download statistics by month:
Online download statistics by month: May 2022 to March 2024
Abstract
Full
Pdf
May 2022
946
81
43
Jun 2022
1014
53
25
Jul 2022
365
20
9
Aug 2022
184
24
11
Sep 2022
739
47
26
Oct 2022
306
38
17
Nov 2022
169
12
8
Dec 2022
83
4
4
Jan 2023
139
14
6
Feb 2023
226
32
17
Mar 2023
164
30
19
Apr 2023
110
18
10
May 2023
148
13
3
Jun 2023
53
2
2
Jul 2023
126
5
3
Aug 2023
79
5
4
Sep 2023
71
3
1
Oct 2023
60
7
7
Nov 2023
53
13
6
Dec 2023
82
13
6
Jan 2024
60
7
11
Feb 2024
55
12
8
Mar 2024
49
7
1
Total
5281
460
247
Read the full text or download the PDF:
Subscribe
Log in
Log in via Institution
Log in via OpenAthens
Log in using your username and password
For personal accounts OR managers of institutional accounts
Username
*
Password
*
Forgot your log in details?
Register a new account?
Forgot
your user name or password?
PDF